Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Access signs licensing agreement with Paladin to market amlexanox in Canada

Aug. 27, 1998

Incert appears to prevent the formation of postoperative adhesions

Aug. 26, 1998

Toray reports kappa agonists for treating dermatological disorders

Aug. 25, 1998

Access licensee files for U.K. approval of amlexanox oral paste

Aug. 24, 1998

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Aug. 24, 1998

Wound-healing efficacy of PGI2 analogue confirmed in preclinical models

Aug. 13, 1998

Phase II study finds IL-2 fusion protein effective but toxic in patients with psoriasis

July 27, 1998

Antipsoriatic dihydrofolate reductase inhibitors available for licensing from BTG

July 22, 1998

Altana offer to license Solarase accepted by Hyal

July 21, 1998

Celgene cleared to market Thalomid in U.S.

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...